Caspase-9

Caspase-9

Introduction

Caspase 9 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Caspase-9 is encoded by the [CASP9](/proteins/casp9-protein) gene. It is a Caspase family, initiator caspases involved in caspase-9 is the initiator caspase of the intrinsic apoptotic pathway. it is activated by the apopto... [@li1997]

<div class="infobox infobox-protein"> [@thornberry1998]
<table> [@green2005]
<tr><th colspan="2" style="background:#f0f0f0;">Caspase-9</th></tr> [@riedl2004]
<tr><td><strong>Protein Name</strong></td><td>Caspase-9</td></tr> [@holcik2001]
<tr><td><strong>Gene</strong></td><td>[CASP9](/genes/casp9)</td></tr> [@datta2000]
<tr><td><strong>UniProt ID</strong></td><td>[P55211](https://www.uniprot.org/uniprot/P55211)</td></tr> [@yuan2000]
<tr><td><strong>PDB ID(s)</strong></td><td>1JXQ, 1KZX, 1KZY, 2J9O, 3MS3, 3MS4, 4JXU</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>46.6 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondria, Cytoplasm</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Caspase family, initiator caspases</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Structure

Caspase-9 is synthesized as an inactive proenzyme (46 kDa) with an N-terminal prodomain. Upon activation, it forms a tetramer with two catalytic subunits.

Caspase-9

Introduction

Caspase 9 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Caspase-9 is encoded by the [CASP9](/proteins/casp9-protein) gene. It is a Caspase family, initiator caspases involved in caspase-9 is the initiator caspase of the intrinsic apoptotic pathway. it is activated by the apopto... [@li1997]

<div class="infobox infobox-protein"> [@thornberry1998]
<table> [@green2005]
<tr><th colspan="2" style="background:#f0f0f0;">Caspase-9</th></tr> [@riedl2004]
<tr><td><strong>Protein Name</strong></td><td>Caspase-9</td></tr> [@holcik2001]
<tr><td><strong>Gene</strong></td><td>[CASP9](/genes/casp9)</td></tr> [@datta2000]
<tr><td><strong>UniProt ID</strong></td><td>[P55211](https://www.uniprot.org/uniprot/P55211)</td></tr> [@yuan2000]
<tr><td><strong>PDB ID(s)</strong></td><td>1JXQ, 1KZX, 1KZY, 2J9O, 3MS3, 3MS4, 4JXU</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>46.6 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondria, Cytoplasm</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Caspase family, initiator caspases</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Structure

Caspase-9 is synthesized as an inactive proenzyme (46 kDa) with an N-terminal prodomain. Upon activation, it forms a tetramer with two catalytic subunits.

Normal Function

Caspase-9 is the initiator caspase of the intrinsic apoptotic pathway. It is activated by the apoptosome (Apaf-1 + cytochrome c) and then cleaves and activates executioner caspases-3, -6, and -7. Caspase-9 activity is regulated by Bcl-2 family proteins and inhibitor of apoptosis proteins (IAPs).

Role in Disease

Alzheimer's Disease

Mitochondrial dysfunction leads to cytochrome c release and apoptosome activation, triggering caspase-9 cascade.

Parkinson's Disease

Caspase-9 is activated in dopaminergic [neurons](/entities/neurons) following mitochondrial Complex I inhibition and PINK1/Parkin pathway dysfunction.

Stroke

Ischemic injury triggers mitochondrial permeabilization and caspase-9 mediated neuronal death.

Traumatic Brain Injury

Secondary injury involves mitochondrial dysfunction and caspase-9 activation.

Therapeutic Targeting

Caspase-9 specific inhibitors (LEHD-FMK) are being studied for neuroprotection in stroke and traumatic brain injury.

Molecular Mechanisms

Apoptosome Activation

Caspase-9 is activated through the intrinsic (mitochondrial) apoptotic pathway:

Structural Features

• N-terminal CARD domain: Protein-protein interactions with Apaf-1
• Prodomain: ~140 amino acids
• Catalytic subunits: Large (p37) and small (p12) subunits after cleavage
• Active tetramer: Two catalytic dimers

Regulation

Caspase-9 is regulated by:

• IAPs (Inhibitor of [Apoptosis](/entities/apoptosis) Proteins): XIAP directly inhibits caspase-9
• Bcl-2 family: Anti-apoptotic proteins (Bcl-2, Bcl-xL) prevent cytochrome c release
• Phosphorylation: Akt phosphorylates caspase-9 at Ser196, inhibiting activity
• Alternative splicing: Caspase-9L (long isoform) has different activity

Brain Region Vulnerability

Caspase-9 activation varies across brain regions:

• High susceptibility: Hippocampal CA1 neurons, cortical layer 5 pyramidal neurons
• Moderate: Dopaminergic neurons in substantia nigra
• Lower: Cerebellar neurons

Animal Models

Knockout Mice

• Caspase-9 knockout mice: Embryonic lethal (defects in brain development)
• Conditional knockout in neurons: Protected from some forms of excitotoxicity

Transgenic Models

• Neuronal caspase-9 activation reporters
• Fluorescent caspase-9 substrates for in vivo imaging

Therapeutic Strategies

Inhibitors

• LEHD-FMK: Irreversible caspase-9 inhibitor
• Z-LEHD-FMK: Cell-permeable inhibitor
• Small molecule inhibitors: Under development for stroke and TBI

Modulators

• IAP antagonists (Smac mimetics): Sensitize cells to apoptosis
• Bcl-2 antagonists: Enhance apoptotic sensitivity
• Akt activators: Inhibit caspase-9 phosphorylation

Biomarkers

Caspase-9 activation can be measured:

• Activity assays: Fluorometric substrates
• Cleavage products: Western blot for p37/p10 fragments
• Caspase-9 activity in CSF: Potential biomarker for neurodegeneration

Background

The study of Caspase 9 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Key Publications

See Also

• CASP9 Gene
• [Apoptosis Pathway](/mechanisms/apoptosis-neurodegeneration) [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)

External Links

• [UniProt: Caspase-9](https://www.uniprot.org/uniprot/P55211)
• [PDB: Caspase-9](https://www.rcsb.org/)
• [Human Protein Atlas: CASP9](https://www.proteinatlas.org/)

Allen Brain Atlas Resources

• Allen Human Brain Atlas: [CASP9 gene expression](https://human.brain-map.org/microarray/search/show?search_term=CASP9)
• Allen Mouse Brain Atlas: [CASP9 expression](https://mouse.brain-map.org/search/index.html?query=CASP9)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Atlas: [CASP9 developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=CASP9)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Caspase-9 discovered through SciDEX knowledge graph analysis: